Showing 1 - 20 results of 68 for search '"Cancer Immunology, Immunotherapy"', query time: 0.09s Refine Results
  1. 1
    Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy

    Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy by Shishengnan Song, Chong Wang, Yangchao Chen, Xiaorong Zhou, Yi Han, Haijian Zhang

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone

    Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone by Tomohiko Yagi, Shunsuke Kagawa, Shohei Nogi, Atsuki Taniguchi, Masashi Yoshimoto, Kanto Suemori, Yasuo Nagai, Shuto Fujita, Shinji Kuroda, Satoru Kikuchi, Yoshihiko Kakiuchi, Fuminori Teraishi, Kosei Takagi, Toshiaki Ohara, Hiroshi Tazawa, Toshiyoshi Fujiwara

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor

    Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor by Soyoko Morimoto, Yukie Tanaka, Jun Nakata, Fumihiro Fujiki, Kana Hasegawa, Hiroko Nakajima, Sumiyuki Nishida, Akihiro Tsuboi, Naoki Hosen, Naoki Kagawa, Motohiko Maruno, Akira Myoui, Takayuki Enomoto, Shuichi Izumoto, Mitsugu Sekimoto, Naoya Hashimoto, Toshiki Yoshimine, Atsushi Kumanogoh, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Differential T cell accumulation within intracranial and subcutaneous melanomas is associated with differences in intratumoral myeloid cells

    Differential T cell accumulation within intracranial and subcutaneous melanomas is associated with differences in intratumoral myeloid cells by Katarzyna Stasiak, Aaron D. Stevens, Ashley C. Bolte, Colleen T. Curley, Mirna Perusina Lanfranca, Robin S. Lindsay, Ukpong B. Eyo, John R. Lukens, Richard J. Price, Timothy N. J. Bullock, Victor H. Engelhard

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung cancer: an open-label, single-arm, multicenter, multi-cohort phase II trial

    Efficacy and safety of surufatinib plus toripalimab in treatment-naive, PD-L1-positive, advanced or metastatic non-small-cell lung cancer and previously treated small-cell lung can... by Ying Cheng, Panpan Zhang, Ming Lu, Zhendong Chen, Lijie Song, Si Shi, Feng Ye, Xing Zhang, Baorui Liu, Dongmei Ji, Yanqiao Zhang, Weiguo Su, Michael Shi, Songhua Fan, Panfeng Tan, Chen Zhong

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma

    Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma by Maki Todo, Yodo Gatate, Shintaro Nakano, Go Kaneko, Masayuki Hagiwara, Takayuki Takahashi, Yuta Umezawa, Genji Ueda, Shiho Ishikawa, Yoshinori Makino, Masafumi Oyama, Suguru Shirotake

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer

    Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer by Julie Tsu-Yu Wu, June Corrigan, Chloe Su, Clark Dumontier, Jennifer La, Aparajita Khan, Shipra Arya, Alex H. S. Harris, Leah Backhus, Millie Das, Nhan V. Do, Mary T. Brophy, Summer S. Han, Michael Kelley, Nathanael R. Fillmore

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer

    Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer by Fangze Wei, Xiaotian Xu, Jing Wang, Shi Wen Mei, Fu Qiang Zhao, Fei Huang, Ti Xian Xiao, Guo Jing Wang, Baojun Wei, Shengkai Huang, Wei Cui

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny

    PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macroph... by Mohammad A. Alzubi, Theresa Barberi, Alan D. Friedman

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist

    Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist by Jarosz-Biej Magdalena, Czapla Justyna, Ciepła Joanna, Smolarczyk Ryszard, Drzyzga Alina, Sprus-Lipka Dorota, Pilny Ewelina, Matuszczak Sybilla, Cichoń Tomasz

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    “Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany

    “Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany by Barbara Seliger

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells

    Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells by Kohei Mitsuno, Masaya Suematsu, Yuki Naito, Azusa Mayumi, Hideki Yoshida, Shinya Osone, Toshihiko Imamura, Yozo Nakazawa, Shigeki Yagyu, Tomoko Iehara

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization

    Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization by Cunzhen Zhang, Yan Fang, Mengxue Guo, Liming Tang, Yurong Xing, Jun Zhou, Yuanyuan Guo, Yuhan Gu, Qiang Wen, Na Gao, Haiwei Xu, Hailing Qiao

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia

    Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia by Haotian Ma, Zhifeng Yan, Runxia Gu, Yingxi Xu, Shaowei Qiu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Min Wang, Jianxiang Wang

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    The profiles of immunosuppressive microenvironment in the Lauren intestinal-type gastric adenocarcinoma

    The profiles of immunosuppressive microenvironment in the Lauren intestinal-type gastric adenocarcinoma by Qingyuan Wang, Jia Chen, Yaohui Wang, Xiang Li, Xiaochun Ping, Jiajia Shen, Sheng Yang, Lizong Shen

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy

    Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy by Haochuan Ma, Dili Song, Haibo Zhang, Taidong Li, Xing Jin

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Correction: Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal

    Correction: Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal by Xinya Li, Zaiwei Song, Yixuan Chen, Jingjing Wu, Dan Jiang, Zhen Zhang, Zeyuan Wang, Rongsheng Zhao

    Published 2025-01-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Targeting BCMA in multiple myeloma: designs, challenges, and future directions

    Targeting BCMA in multiple myeloma: designs, challenges, and future directions by Yi Hu, Yuetao Xie, Xiaodong Wang, Lufeng Yang, He Geng, Zugang Yi, Yao Zhang, Lin Ma, Fang Chen

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors

    Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors by Mina Cho, Hyun Chang, Ju Han Kim

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma

    Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma by Yu-zhe Cao, Jia-yu Pan, Guang-lei Zheng, Chao An, Meng-Xuan Zuo

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: